Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial
Journal of Cardiovascular Electrophysiology · 2026-07 · 37 (7) · 1410-1420
DOI: 10.1111/jce.70357 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 03.05.2026. Verfasst von Koji Kumagai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan. Hauptthemen laut MEDLINE: Catheter Ablation, Atrial Fibrillation, Pulmonary Veins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan.
Abstract (Originalsprache)
Background
The role of dominant frequency (DF)–guided ablation after pulmonary vein isolation (PVI) in persistent atrial fibrillation (AF) remains uncertain. We evaluated the clinical and mechanistic impact of DF mapping in a multicenter randomized study. Methods and Results In this multicenter, prospective study, 103 patients were enrolled. Patients with high‐DF sites (≥ 7 Hz) were randomized 1:1 to PVI plus DF ablation (DF group, n = 32) or PVI alone (PVI group, n = 32). Patients without high‐DF sites (< 7 Hz, n = 39) underwent PVI only (non‐DF group; exploratory cohort). The primary endpoint was freedom from documented AF recurrence without antiarrhythmic drugs (AADs) at 12 months. AF‐free survival off AADs was 81.3% in the DF group versus 68.9% in the PVI group ( p = 0.228) at 12 months. Arrhythmia‐free survival with or without AADs was 78.1% versus 65.6% ( p = 0.263). The non‐DF group showed the most favorable outcomes (83.3%, p = 0.065 vs PVI group). No adverse events were associated with DF mapping or ablation. Multivariate analysis identified right atrial (RA) low‐voltage area extent (HR 1.031, 95% CI 1.005–1.058, p = 0.018) and LA diameter (HR 0.899, 95% CI 0.816–0.991, p = 0.032) as independent predictors of recurrence.
Conclusions
In this multicenter randomized trial, adjunctive DF‐guided ablation following PVI did not result in a statistically significant improvement in arrhythmia‐free survival compared with PVI alone. However, the absence of high‐DF sites was associated with favorable outcomes, and RA low‐voltage burden emerged as an independent predictor of recurrence, supporting the potential mechanistic value of DF mapping and highlighting the prognostic importance of right atrial structural remodeling. Trial Registration UMIN000042543.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
- Division of Cardiology, Mito Saiseikai General Hospital, Ibaraki, Japan.
- Division of Cardiology, Yamagata University Hospital, Yamagata, Japan.
- Division of Cardiology, University of Tsukuba Hospital, Ibaraki, Japan.
- Division of Cardiology, Fujita Health University, Aichi, Japan.
- Division of Cardiology, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
ORCID-Profile: Yuichi Hanaki, Masahide Harada, Kazuki Noda, Hirohito Metoki
Förderung
- Japanese Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan
Zitieren
APA
Kumagai, K., Hasegawa, T., Kutsuzawa, D., Hanaki, Y., Harada, M., Hachiya, H., Hasebe, Y., Noda, K., Yambe, M., Metoki, H., & Aonuma, K. (2026). Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial. Journal of Cardiovascular Electrophysiology, 37(7), 1410-1420. https://doi.org/10.1111/jce.70357
Vancouver
Kumagai K, Hasegawa T, Kutsuzawa D, Hanaki Y, Harada M, Hachiya H, et al. Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial. Journal of Cardiovascular Electrophysiology. 2026;37(7):1410-1420. doi:10.1111/jce.70357
BibTeX
@article{Kumagai2026,
author = {Kumagai, Koji and Hasegawa, Tomoaki and Kutsuzawa, Daisuke and Hanaki, Yuichi and Harada, Masahide and Hachiya, Hitoshi and Hasebe, Yuhi and Noda, Kazuki and Yambe, Minoru and Metoki, Hirohito and Aonuma, Kazutaka},
title = {Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {7},
pages = {1410--1420},
doi = {10.1111/jce.70357}
}
EUVIMED